scispace - formally typeset
Open AccessJournal ArticleDOI

Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy

TLDR
This paper reviews the most significant advancements in protein nanoparticle technology and their use in drug delivery arena, and examines the various sources of protein materials that have been used successfully for the construction of protein nanoparticles as well as their methods of preparation.
Abstract
Nanoparticles have increasingly been used for a variety of applications, most notably for the delivery of therapeutic and diagnostic agents. A large number of nanoparticle drug delivery systems have been developed for cancer treatment and various materials have been explored as drug delivery agents to improve the therapeutic efficacy and safety of anticancer drugs. Natural biomolecules such as proteins are an attractive alternative to synthetic polymers which are commonly used in drug formulations because of their safety. In general, protein nanoparticles offer a number of advantages including biocompatibility and biodegradability. They can be prepared under mild conditions without the use of toxic chemicals or organic solvents. Moreover, due to their defined primary structure, protein-based nanoparticles offer various possibilities for surface modifications including covalent attachment of drugs and targeting ligands. In this paper, we review the most significant advancements in protein nanoparticle technology and their use in drug delivery arena. We then examine the various sources of protein materials that have been used successfully for the construction of protein nanoparticles as well as their methods of preparation. Finally, we discuss the applications of protein nanoparticles in cancer therapy.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Effect of the surface modification, size, and shape on cellular uptake of nanoparticles.

TL;DR: The influence of size, shape, the surface modification of nano particles, medium, and cell division effects on the cellular absorption of drug/gene nanocarriers is reviewed.
Journal ArticleDOI

Nanoprecipitation process: From encapsulation to drug delivery

TL;DR: In general, in vitro drug release from nanoparticles prepared by nanoprecipitation includes two phases: a first phase of "burst release" which is followed by a second phase of prolonged release.
Journal ArticleDOI

DNA Vaccines-How Far From Clinical Use?

TL;DR: Improvements in DNA vaccine design include the use of APC-specific promotors for transcriptional targeting, the arrangement of multiple antigen sequences, the co-delivery of molecular adjuvants to prevent tolerance induction, and strategies to circumvent potential inhibitory effects of the vector backbone.
References
More filters
Journal ArticleDOI

Environment-sensitive hydrogels for drug delivery

TL;DR: Development of environmentally sensitive hydrogels with a wide array of desirable properties can be made is a formidable challenge, however, if the achievements of the past can be extrapolated into the future, it is highly likely that responsive hydrogelWith such properties can been made.
Journal ArticleDOI

Biodegradable polymeric nanoparticles as drug delivery devices

TL;DR: This review presents the most outstanding contributions in the field of biodegradable polymeric nanoparticles used as drug delivery systems from 1990 through mid-2000.
Journal ArticleDOI

Biodegradable long-circulating polymeric nanospheres

TL;DR: Monodisperse biodegradable nanospheres were developed from amphiphilic copolymers composed of two biocompatible blocks and exhibited dramatically increased blood circulation times and reduced liver accumulation in mice.
Journal Article

Drug delivery and targeting

TL;DR: When a pharmaceutical agent is encapsulated within, or attached to, a polymer or lipid, drug safety and efficacy can be greatly improved and new therapies are possible.
Journal ArticleDOI

Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.

TL;DR: This review gives an account of the different drug delivery systems which make use of albumin as a drug carrier with a focus on those systems that have reached an advanced stage of preclinical evaluation or that have entered clinical trials.
Related Papers (5)